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Histopathological examination, grading, immunohistochemical staining and molecular 
genetic examinations are the proposed criteria that should be used for cutaneous mast 
cell tumors (CMCTs) classifi cation. The presence of  aberrant CD117 expression and 
mutations of  the c-kit proto-oncogene could be an indicative parameter for fi nal 
histological grading. Determination of  the connection between the localization of  KIT 
receptor expression and the histological grade of  CMCTs without c-kit proto-oncogene 
mutations was the main goal of  this study. The study included twenty four CMCTs 
and six control skin samples from 30 dogs of  different ages, breed and sex. Formalin-
fi xed and paraffi n-embedded tissue samples were stained with hematoxylin-eosin and 
toluidine blue and immunohistochemically tested for CD117 expression. DNA was 
extracted from the same paraffi n blocks and subsequent polymerase chain reaction 
amplifi cation was performed using PE1 and PE2 primers. Degree of  malignancy was 
determined based on the presence of  mitotic fi gures, multinucleated cells, bizarre 
nuclei and karyomegaly in 10 high power fi elds. Based on histological features, fourteen 
of  24 CMCTs were of  a high histological grade, while ten were classifi ed as a low-
grade malignancy. CD117 cytoplasmic expression was observed in nine of  fourteen 
high-grade malignancy CMCTs, which confi rms the link between the aberrant CD117 
expression and increased cell proliferation. 
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INTRODUCTION
Within all round cell tumors that can be diagnosed in dogs, cutaneous mast cell tumors 
(CMCTs) are the most frequent, comprising 7% to 21% of  all skin neoplasms [1-3].
The etiology of  CMCTs is probably multifactorial [1,4]. An early study suggested a viral 
etiology, but ultrastructural examinations have not revealed virus or virus-like particles 
[5]. Recent work has implied that the transmembrane tyrosine kinase receptor (KIT) 
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that binds the ligand stem cell factor (SCF) is an important factor in the pathogenesis 
of  canine CMCTs [6]. Mutations of  the c-kit proto-oncogene could also be involved 
in CMCT pathogenesis [7-9].
The most commonly used histological grading systems for canine CMCTs are those 
developed by Patnaik et al. and Kiupel et al. [10,11].
A large number of  grade II CMCTs and interobserver variations are the major weak 
points of  the Patnaik grading system [12]. The Kiupel grading system eliminates 
ambiguity of  intermediate-grade CMCTs and grading criteria are relatively simple and 
less infl uenced by subjective inter-observer variation in comparison with the Patnaik 
grading system [11,13].  According to Kiupel grading system, high-grade CMCTs 
include neoplasms with at least one of  the following features: at least 7 mitotic fi gures 
in 10 high power fi elds (hpf); at least 3 multinucleated cells in 10 hpf; at least 3 bizarre 
nuclei in 10 hpf; or at least 10% karyomegalic cells of  the neoplastic cells [11].
The predictive value of  KIT receptor expression has been examined recently 
[8,9,14,15]. Normal and some neoplastic mast cells have only membranous KIT 
localization while in many neoplastic mast cells KIT accumulation is noticed in the 
cytoplasm [8,14-16]. Some authors emphasize a correlation between the expression 
of  the KIT receptor and the histological grade of  CMCTs [16,17] and others believe 
that there is a correlation between the degree of  CMCT differentiation and the KIT 
expression pattern [8].
A signifi cant association between the aberrant KIT expression and the presence of  
c-kit proto-oncogene mutations has been identifi ed in dogs with CMCTs. However, 
mutations were not present in all CMCT samples with aberrant KIT expression [18]. 
The c-kit proto-oncogene encodes the receptor tyrosine kinase [9].
The aim of  our study was to determine the connection between the localization of  
KIT receptor expression in CMCTs without c-kit proto-oncogene mutations and the 
histological grade of  CMCTs.
MATERIAL AND METHODS
Animals
A subset of  24 dogs from the Faculty of  Veterinary Medicine medical database was 
searched for diagnoses of  canine cutaneous CMCT. The skin samples of  dogs were 
sampled in different veterinary clinics from the Republic of  Serbia. Additional data 
including age, sex, breed, and location of  the mass, were obtained from referring 
veterinarians. Intact skin samples from 6 necropsied adult dogs were used as the 
control. 
DNA Isolate
Known dog DNA isolate containing c-kit mutation (Michigan State University, USA) 
was used as a positive control for this mutation. 
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Histopathology
Initial diagnosis and grading of  tumors were made using hematoxylin (HE) and 
Toluidine blue staining (TB).
Histopathological features of  CMCTs, such as the number of  mitotic fi gures, the 
presence of  multinucleated cells, bizarre nuclei and karyomegaly were evaluated on 
the HE stained sections. Each parameter was observed on 10 hpf  (400x). 
Immunohistochemical staining
Formalin-fi xed paraffi n embedded tissue samples were cut to 5μm sections and the 
three-step indirect immunohistochemical (IHC) technique was performed. Antigen 
retrieval was achieved by heating the sections in a microwave oven at 560 W for 
21 minutes in a citrate buffer (pH 6.0). The sections were treated with methanol 
containing 0.3% hydrogen peroxide for 15 minutes at room temperature in order 
to inactivate endogenous peroxidase. Nonspecifi c binding of  secondary antibodies 
was minimized by incubating with 50% normal goat serum in PBS for 20 min. The 
sections were incubated with primary antibodies diluted in phosphate buffer saline 
(pH 7.2) for 1 h in a humid chamber at 22±3°C. For immunohistochemical staining 
CD117, polyclonal rabbit  anti-human antibody (DAKO, A4502) was used diluted 
1:400. The immunoreaction was visualized with DAB+ (3,3’-diaminobenzidine 
tetrahydrochloride, DAKO, K3468). Sections were counterstained with Mayer’s 
hematoxylin. Aqueous medium glycergel (DAKO, C563) was used on the stained 
sections for mounting. Appropriate positive and negative controls were used.
Evaluation of CD117 immunostaining
CD117 immunohistochemical labeling was evaluated by identifying areas with the 
highest proportion of  immunopositive neoplastic mast cells at 100 x magnifi cation. 
After determination of  highly proliferative areas, a 1 cm2 (10 x 10 mm) grid reticle 
at 400x magnifi cation was used for counting the number of  immunopositive cells 
present in a 10 x 10 mm grid area. The number of  immunopositive cells per grid 
area was determined in 10 hpf  fi elds and subsequently averaged to obtain the growth 
fraction.
All slides were assigned one of  3 KIT staining patterns: perimembrane (KIT staining 
pattern I), focal cytoplasmic (KIT staining pattern II), or diffuse cytoplasmic 
localization (KIT staining pattern III). Neoplastic mast cells that have primarily 
immunohistochemically stained membrane with only minimal cytoplasmic staining are 
characteristic for the CMCTs with KIT staining pattern I. KIT staining pattern II was 
characterized by neoplastic mast cells with focal to stippled cytoplasmic KIT protein 
localization. Membrane associated staining was not a prominent feature of  these cells. 
KIT-staining pattern III was defi ned by neoplastic mast cells with diffuse cytoplasmic 
staining, obscuring all other cytoplasmic features.
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Polymerase chain reaction (PCR)
DNA was extracted from the paraffi n blocks using the commercial set „KAPA 
Express Extract KIT” (Cat. No KK7152, Kapa Biosystems, Cape Town, South Africa) 
according to the manufacturer’s instructions. The primers used for PCR amplifi cation 
of  the c-kit juxtamembrane domain were PE1 (CCA TGT ATG AAG TAC AGT 
GGA AG) and PE2 (GTT CCC TAA AGT CAT TGT TAC ACG) [7]. These primer 
pairs were expected to generate a PCR product size of  ~191 bp and another of  
~250bp. The thermal protocol consisted of  an initial denaturation step at 95°C for 
3 min, followed by 40 cycles of  denaturation (94°C, 15 sec), annealing (59°C, 15 sec) 
and DNA extension (72°C, 15 sec), and a fi nal extension step at 72°C for 5 min. PCR 
products were separated by electrophoresis on a 2% agarose gel, stained with ethidium 
bromide, and “visualized” with UV light. The presence of  mutations was determined 
by visual examination of  the gel images.
Statistical analysis
The obtained results were analyzed using descriptive methods such as mean and 
standard deviation. Comparison of  the data and signifi cance determination were 
performed by the Chi-square test. The signifi cance was determined on a 5% and 1% 
level of  signifi cance.
RESULTS
Determination of age, breed and topographic related distribution
of CMCTs in the examined dogs
The mean age of  the dogs with CMCT was 7.56±2.45 years. The following breeds 
were affected with CMCT: Golden Retrievers (n = 9), Boxers (n = 5), Labradors (n = 
3), American Bulldogs (n = 2), Fox Terrier (n = 1), Dogo Argentino (n = 1), Maltese 
(n = 1), American Staffordshire Terrier (n = 1) and mixed breed (n = 1). Tumors were 
located on the limbs (n = 10),  thorax (n = 9),  abdomen (n = 3) and the head (n = 2). 
Seventeen dogs were male and 7 were female.
Morphological characteristics of CMCTs
According to the observed parameters in CMCTs and based on the propositions of  
the Kiupel grading system, the examined CMCTs were divided into two categories: 14 
high grade and 10 low grade CMCTs.
Mitotic Index (MI)
All tumors were evaluated to determine the average mitotic index (MI). More than 
6 mitotic fi gures per 10 hpf  were observed in 29.17% of  total CMCTs (Figure 1A), 
while 70.83% of  total CMCTs had a low mitotic index (less than 6 mitotic fi gures per 
10 hpf). Mitotic fi gures were present in 50% of  high grade mast cell tumors.
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Presence of multinucleated cells, bizarre nuclei and karyomegaly
The presence of  more than two multinucleated cells per 10 hpf  (Figure 1B) was 
observed in 45.83% of   total CMCTs and in 78.57% of  high grade mast cell tumors.
More than two cells with bizarre nuclei per 10 hpf  were present in 41.67% of  total 
CMCTs. Bizarre nuclei were observed in 71.43% of  high grade mastocytoma (Figure 
1C). 
More than 10% of  anaplastic mast cells with a nucleus diameter greater than 8μm were 
observed in 33.33% of  total CMCTs. In high grade mast cell tumors cariomegaly was 
present in 57.14% (Figure 1D).
Microscopic fi ndings on toluidine blue stained slides
In all the observed CMCT samples, cytoplasmic granules showed metachromasia. 
(Figure 2A and 2B). Intense degranulation of  mast cells was observed in 50% of  
CMCTs (in 1 of  10 low grade and in 11 of  14 high grade CMCTs).
Figure 1. Skin, Dog: A) Presence of  mitotic fi gures (arrow) in high grade mast cell tumors, 
HE, 400x; B) Presence of  multinucleated cells (arrow) in high grade mast cell tumors, HE, 
400x; C) Presence of  cells with bizarre nuclei (arrow) in high grade mast cell tumors, HE, 400x; 
D) Presence of  karyomegaly (arrow) in high grade mast cell tumors, HE, 400x
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Immunohistochemical parameters relevant for CMCT classifi cation 
KIT receptor (CD117) immunoexpression in CMCTs
The majority of  CMCTs in this study had KIT-staining pattern I (62.5%) (Figure 2C). 
This group included all low grade CMCTs and 5 of  14 high grade CMCTs. A total 
of  20.8% of  CMCTs showed KIT-staining pattern II (Figure 2D), while none of  
the CMCTs had only KIT-staining pattern III. All CMCTs that showed KIT-staining 
pattern II were high grade CMCTs. Different KIT-staining patterns were detected 
in12.5% of  CMCTs that had both membranous and focal cytoplasmic expression 
(Figure 2E), as well as in 4.2% of  CMCTs with a membranous/diffuse cytoplasmic 
pattern (Figure 2F).
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Figure 2. Skin, Dog: A) High density of  cytoplasmic granules in mast cell tumors, TB, 400x; 
B) Low density of  cytoplasmic granules in mast cell tumors, TB, 400x; C) KIT expression, 
membranous expression, CD117, LSAB2, 400x; D) KIT expression,  diffuse cytoplasmic 
expression, CD117, LSAB2, 400x; E) KIT expression, membranous and focal cytoplasmic 
expression, CD117, LSAB2, 400x; F) KIT expression, membranous (arrow) and diffuse 
cytoplasmic (arrowhead) expression, CD117, LSAB2, 400x
The obtained results showed that there was no statistically signifi cant difference 
between different types of  cytoplasmic KIT expression in high grade CMCTs (p= 
0, 285049). The relation between the different types of  KIT expression and the 
histological degree is shown in Chart 1.
c-KIT Mutation Analysis
No c-KIT mutations (presence of  ITD in exon 11) were demonstrated in any of  the 
24 CMCTs (Figure 3). The positive control showed two bands (150bp and 250bp).
Chart 1. KIT immunohistochemical pattern in 24 MTCs classifi ed according to the histological 
grade: M-membranous; CD-diffuse cytoplasmic; CF-focal cytoplasmic; MFC- membranous/ 
focal cytoplasmic; MDC-membranous/ diffuse cytoplasmic
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DISCUSSION
Among the nine dog breeds included in this study, the highest frequency of  CMCTs 
was observed in golden retrievers (37.5%), and followed by boxers (20.7%) which 
refl ect a well-known breed predisposition [1,14,18].
According to previous studies, CMCTs were mostly localized on limbs [19,20],  or  on 
the trunk [1]. Based on our study, the localization was predominately on the limb skin, 
similar to other results.
Using the propositions of  the Kiupel grading system, we observed more than six 
mitotic fi gures in 10 hpf  in 50% of  high grade CMCTs, so the presence of  mitotic 
fi gures was not statistically signifi cant (p>0.05) in this study. While some authors 
believe that CMCTs of  grades I and II according to the Patnaik classifi cation can 
also metastasize, and therefore the mitotic index cannot be the only reliable factor to 
predict tumor behavior [9,10], other authors consider that the mitotic activity is a key 
prognostic factor of  the long-term outcome [11,21]. One of  the criteria of  the Kiupel 
grading system is that high-grade CMCTs have at least 7 mitotic fi gures in 10 hpf  [11].
The presence of  multinucleated mast cells is characteristic of  higher-grade cutaneous 
CMCTs [10]. In our study more than two multinucleated cells per 10 hpf  were 
observed in 78.57% of  high grade CMCTs, while none were present in low grade 
CMCTs. According to these results multinucleation was signifi cantly associated with 
higher malignancy. 
Figure 3. PCR amplifi cation of  exon 11 of  c-KIT proto-oncogene; M - Marker, 1 - positive 
control with KIT ITD, 2 - positive control with KIT ITD, 3 PCR product without KIT ITD, 
4 - PCR product without KIT ITD
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Cells with poorly marked membranes and large nuclei of  irregular shape, as well as 
multinucleated cells were observed in poorly differentiated CMCTs. More than 10% 
of  anaplastic mast cells with 8-10μm nuclei diameter were observed in 57.14% of  
examined high grade CMCTs. This indicates that karyomegaly cannot be considered 
as a signifi cant predictive factor in this study. 
Unlike previous papers which studied the relationship between the intensity of  CD117 
immunohistochemical expression and the degree of  CMCT differentiation [16], 
our study revealed an association between the aberrant CD117 expression and the 
histological degree of  CMCTs.
In all low grade CMCTs in this study, only membrane-associated CD117 expression 
was observed, while both membrane-associated and cytoplasmic CD117 expression 
occur in high grade CMCTs. Despite the fact that cytoplasmic expression of  CD117 is 
characteristic of  a high grade tumor, no signifi cant differences were observed between 
the expressions of  focal or diffuse cytoplasmic CD117 staining pattern related to the 
histological grade of  CMCT. This suggests that both type of  cytoplasmic staining 
may indicate similar cellular changes and cytoplasmic accumulation of  CD117 [14]. 
However, there is a connection between aberrant expression of  CD117 and the 
degree of  CMCT differentiation. Increase in cytoplasmic accumulation of  CD117 
is connected with more aggressive biological behavior of  canine cutaneous CMCTs 
[8,22]. On the other hand, there is an opinion that diffuse CD117 expression is present 
in clinically benign tumors or in tumors of  the fi rst grade of  malignancy according 
to Patnaik and only focal cytoplasmic CD117 expression is characteristic of  poorly 
differentiated (grade III) CMCTs [17].
C-kit mutations are mostly the characteristic of  CMCTs of  higher histological grade 
[9,15,23,24]. It has been suggested that these mutations play a role in the malignant 
transformation of  CMCTs [24]. They have been shown to correlate with aberrant 
CD117 expression, although mutations were not present in all CMCTs with aberrant 
CD117 expression [18] . Some of  the tumor samples we examined had aberrant CD117 
expression while mutations were not detected which confi rms the fact that CMCTs 
with no mutation can also express aberrant CD117 pattern. While the intensity of  KIT 
expression may be affected by inter-observer variability, the KIT immunohistochemical 
pattern (cytoplasmic or membraneous) is a more objective parameter. Therefore, KIT 
staining patterns should be the part of  routinely examination of  canine patients with 
CMCTs together with histological grading and c-KIT mutations.
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EKSPRESIJA KIT RECEPTORA NA KUTANIM 
MASTOCITOMIMA PASA BEZ C-KIT MUTACIJA 
VUČIĆEVIĆ Ivana, MARINKOVIĆ Darko, KUKOLJ Vladimir, VUČIĆEVIĆ 
Miloš, MIRILOVIĆ Milorad, NEŠIĆ Slađan, ALEKSIĆ-KOVAČEVIĆ Sanja
Histopatološko ispitivanje, gradacija, imunohistohemijsko bojenje i molekularno gen-
etska ispitivanja su predloženi kriterijumi za klasifi kaciju kutanih mastocitoma pasa. 
Prisustvo aberantne ekspresije CD117 i mutacija c-kit protoonkogena moglo bi da 
bude indikativni parameter za fi nalnu histopatološku klasifi kaciju mastocitoma. Glavni 
cilj ispitivanja je određivanje povezanosti mesta ekspresije KIT receptora i histološkog 
gradusa mastocitoma bez c-kit mutacija. Ispitivanjima su obuhvaćena 24 mastocitoma 
i 6 kontrolnih isečaka kože uzorkovanih od ukupno 30 odraslih pаsа različitog uz-
rasta, rase i pola. Uzorci fi ksirаni u formalinu i ukаlupljeni u pаrаfi nske kаlupe su bo-
jeni hemаtoksilin-eozinom, toluidin plavo metodom i imunohistohemijski primenom 
CD117 antitela. DNK je izolovana iz istih parafi nskih kalupa, a PCR amplifi kacija je 
izvršena primenom specifi čnih prajmera PE1 i PE2. Stepen malignosti je utvrđen na 
osnovu prisustva mitotskih fi gura, multinuklearnih ćelija, ćelija sa bizarnim jedrom i 
kariomegalije na 10 polja velikog uveličanja. Na osnovu histopatoloških osobina, 14 od 
24 mastocitoma su svrstani u visoki stepen maligniteta, dok je 10 mastocitoma niskog 
stepena maligniteta. Citoplazmatska ekspresija CD117 je uočena kod 9 od 14 mas-
tocitoma visokog stepena maligniteta, što potvrđuje vezu između aberantne ekspresije 
CD117 i povećane ćelijske proliferacije.
